The global biologics safety testing industry valued of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants. Growing pharmaceutical and biotech industry and increasing demand for biological...

The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growing developments of biologics and biosimilars, increased concerns over the cell culture contamination, and rising investments in...

Lucintel's latest market report analyzed that biologics safety testing provides attractive opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing. The biologics safety testing market is expected to reach $8.2 billion...

Biologics safety testing market players and analysis by product, test, application — forecast till 2030. The global biologics safety testing market is expected to grow at a robust 13.6% CAGR over the forecast period (2022 to 2030), according to the latest research report from Market Research Future (MRFR). As biologics are increasingly used in medication development and stem cell...

The global biologics safety testing market size valued of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants. Growing pharmaceutical and biotech industry and increasing demand for biological...

Biologics Safety Testing Market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period according to a new report by MarketsandMarkets™. The growth of the global biologics safety testing market is driven by factors such as companies investing heavily in the development of biologics and biosimilars, strict regulatory...